Allarity Therapeutics Growth Metrics (2024-2025) | ALLR

Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 148.39%-31.34%2.05%-19.39%
Assets (QoQ) (Quarter) 158.02%-34.02%11.15%31.26%-28.67%-1.93%-12.20%
Cash & Equivalents (QoQ) (Quarter) 6,064.42%-4.00%
Cash from Operations Growth (1y) (Quarter) -91.99%24.96%37.35%-1.15%
Cash from Operations (QoQ) (Quarter) -422.09%25.48%41.10%16.22%-104.06%37.79%4.90%
EBITDA Margin Growth (1y) (Quarter) 0.15M3.42M-1.89M-0.59M
EBITDA Margin (QoQ) (Quarter) -0.33M2.31M-1.40M-0.42M2.93M-2.99M-0.11M
EBIT Growth (1y) (Quarter) 28.40%-22.60%79.55%-119.86%
EBIT Margin Growth (1y) (Quarter) 0.12M3.37M-2.02M2.45M
EBIT Margin (QoQ) (Quarter) -0.34M2.38M-4.42M2.49M2.91M-3.00M0.05M
EBIT (QoQ) (Quarter) 20.50%-265.26%219.35%-120.66%-36.13%39.08%-15.89%
EBT Growth (1y) (Quarter) 29.82%-42.42%76.55%-74.27%
EBT Margin Growth (1y) (Quarter) 0.10M1.90M-1.90M0.80M
EBT Margin (QoQ) (Quarter) -0.34M2.36M-3.58M1.66M1.46M-1.44M-0.88M
EBT (QoQ) (Quarter) 57.66%-634.62%174.56%-130.26%14.07%-20.95%181.82%
Enterprise Value Growth (1y) (Quarter) -702.24%-20,413.89%
Enterprise Value (QoQ) (Quarter) -6,064.42%4.00%99.61%-3,376.39%
EPS (Basic) Growth (1y) (Quarter) 99.96%95.51%97.54%-102.17%
EPS (Basic) (QoQ) (Quarter) 99.50%-130.84%225.55%-102.58%40.00%-26.67%-10.53%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) 99.50%
FCF Margin Growth (1y) (Quarter) 0.33M4.40M-0.49M0.12M
FCF Margin (QoQ) (Quarter) 0.03M0.92M-0.66M0.04M4.10M-3.97M-0.05M
Free Cash Flow Growth (1y) (Quarter) -91.99%24.96%37.35%-1.15%
Free Cash Flow (QoQ) (Quarter) -422.09%25.48%41.10%16.22%-104.06%37.79%4.90%
Interest Coverage Ratio Growth (1y) (Quarter) -28.13%-4,252.46%82.06%-125.24%
Interest Coverage Ratio (QoQ) (Quarter) 80.96%-3,012.04%179.57%-127.18%-546.63%87.17%-11.96%
Net Cash Flow Growth (1y) (Quarter) 44,610.53%-142.34%-91.30%-438.48%
Net Cash Flow (QoQ) (Quarter) 100,126.32%-103.03%278.96%721.87%-195.14%86.33%-216.64%
Net Income Growth (1y) (Quarter) 29.74%-42.42%75.79%-74.27%
Net Income (QoQ) (Quarter) 57.61%-611.48%176.99%-130.26%14.07%-20.95%181.82%
Net Income towards Common Stockholders Growth (1y) (Quarter) 29.59%-39.01%76.91%54.74%
Net Income towards Common Stockholders (QoQ) (Quarter) 56.98%-628.10%38.67%63.34%15.08%-20.95%-20.21%
Net Margin Growth (1y) (Quarter) 0.10M1.89M-1.94M-0.42M
Net Margin (QoQ) (Quarter) -0.34M2.39M-1.44M-0.51M1.45M-1.44M0.08M
Operating Income Growth (1y) (Quarter) 28.40%-22.60%79.55%-119.86%
Operating Income (QoQ) (Quarter) 20.50%-265.26%219.35%-120.66%-36.13%39.08%-15.89%
Operating Margin Growth (1y) (Quarter) 0.12M3.37M-2.02M2.45M
Operating Margin (QoQ) (Quarter) -0.34M2.38M-4.42M2.49M2.91M-3.00M0.05M
Profit After Tax Growth (1y) (Quarter) 28.91%-42.42%75.79%54.74%
Profit After Tax (QoQ) (Quarter) 57.61%-611.48%35.69%63.34%15.08%-20.95%-20.21%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) 1,611.11%1,794.12%2,650.00%6.80%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -5.56%-29.41%2,475.00%-0.32%4.55%2.48%0.00%
Return on Assets Growth (1y) (Quarter) 10.00
Return on Assets (QoQ) (Quarter) 11.00-3.0035.00-34.00
Return on Capital Employed Growth (1y) (Quarter) -65.00
Return on Capital Employed (QoQ) (Quarter) 22.00-3.0070.00-155.00
Return on Equity Growth (1y) (Quarter) 15.00
Return on Equity (QoQ) (Quarter) 20.00-4.0059.00-60.00
Return on Invested Capital (QoQ) (Quarter) 15.00-5.00
Return on Sales Growth (1y) (Quarter) 969.000.02M-0.02M0.01M
Return on Sales (QoQ) (Quarter) -0.00M0.02M-0.04M0.02M0.01M-0.01M-0.01M
Revenue Growth (1y) (Quarter) 44.12%97.18%-14.00%21.33%
Revenue (QoQ) (Quarter) -317.65%88.26%-50.00%24.00%78.95%-375.00%-3.51%
Share-based Compensation Growth (1y) (Quarter) 534.38%645.45%676.47%-26.56%
Share-based Compensation (QoQ) (Quarter) 168.75%-22.73%276.47%117.19%17.99%-19.51%-64.39%
Shareholder's Equity Growth (1y) (Quarter) 388.50%-38.66%-7.35%-16.79%
Shareholder's Equity (QoQ) (Quarter) 406.52%-34.64%-8.89%58.06%-34.83%-1.28%-18.18%
Total Debt (QoQ) (Quarter) -99.40%-87.50%-50.00%